arrow
R

Roberta Sanfilippo

Cancer medicine
H指数:33
被引数:5,269

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ASO Visual Abstract: Refining the Contemporary Management of Primary Retroperitoneal Soft Tissue Sarcoma: Outcome Improvement Over Time at a Single Institution

ASO视觉摘要:优化原发性腹膜后软组织肉瘤的现代管理:单机构随时间推移的结局改善

2026-04-270
PRE
Refining the Contemporary Management of Primary Retroperitoneal Soft Tissue Sarcoma: Outcome Improvement Over Time at a Single Institution

优化原发性腹膜后软组织肉瘤的现代管理:单中心随时间推移的结局改善

2025-12-130
PRE
Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase 2 study from the Italian Sarcoma Group

Trabectedin-olaparib联合治疗或trabectedin单药治疗在经蒽环类为基础治疗失败的晚期软组织肉瘤中的应用(TOMAS2):一项来自意大利肉瘤组的随机Ⅱ期研究

2025-12-050
PRE
Extended molecular profiling in mesenchymal tumors: a consensus paper from the Italian Sarcoma Group

间质肿瘤的扩展分子分析:意大利肉瘤组共识论文

2025-09-230
PREAI
Radiomic features of primary retroperitoneal sarcomas: a prognostic study
2024-12-010
PRE
Preoperative nutritional support to tackle morbidity in multivisceral resection for retroperitoneal sarcoma. Early outcomes from a novel nutritional prehabilitation program in a prospective cohort
EJSO
IF2.9
2024-12-012
PRE
A comparative assessment of selinexor with trabectedin or lurbinectedin in patient-derived xenografts (PDX) of dedifferentiated liposarcoma (DDLPS) highlights the effectiveness of their sequential or concomitant combination
2023-12-010
PRE
Efficacy and safety findings from MANTRA: A global, randomized, multicenter, phase III study of the MDM2 inhibitor milademetan vs trabectedin in patients with dedifferentiated liposarcomas
2023-11-011
OA
Efficacy and safety findings from MANTRA: A global, randomized, multicenter, phase III study of the MDM2 inhibitor milademetan vs trabectedin in patients with dedifferentiated liposarcomas
2023-10-012
PRE
TOMAS2: A randomized phase II study from the Italian Sarcoma Group (ISG) of trabectedin plus olaparib (T plus O) or trabectedin (T) in advanced, metastatic, or unresectable soft tissue sarcomas (STS) after failure of standard treatments
2023-10-014
PRE
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis
2022-12-083
OAAI
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments

超罕见肉瘤的回顾性观察性研究: 结缔组织肿瘤学会 (CTOS) 专家社区关于评估全身治疗活动的最低要求的共识论文

2022-11-0116
OAAI
Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group

成人局部复发性腹膜后肉瘤的治疗: 跨大西洋澳大利亚腹膜后肉瘤工作组的最新共识方法

2022-06-2920
PRE